The International Partnership for Microbicides (IPM) announced today that The New England Journal of Medicine (NEJM) has published results from The Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. ...
Dec 1, 2016
0
0
South Africa on Wednesday launched a major clinical trial of an experimental vaccine against the AIDS virus, which scientists hope could be the "final nail in the coffin" for the disease.
Nov 29, 2016
0
48
One in seven people with HIV in Europe is unaware of their infection, the EU and World Health Organization reported Tuesday as 2015 marked another record year for new HIV cases in the region.
Nov 29, 2016
0
3
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves ...
Nov 27, 2016
0
7
A vaginal yeast infection is a fungal infection that causes irritation, discharge and intense itchiness of the vagina and the vulva - the tissues at the vaginal opening. It's a type of vaginitis, or inflammation of the vagina. ...
Nov 25, 2016
0
1
A group of researchers at the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and offers a first glance ...
Nov 23, 2016
0
0
The number of HIV-infected people taking anti-retroviral medicine has doubled in just five years, the UN said Monday, while highlighting high infection rates among young African women.
Nov 21, 2016
0
0
Adelaide researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Nov 21, 2016
1
153
When HIV attacks a T cell, it attaches itself to the cell's surface and launches a "harpoon" to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at ...
Nov 17, 2016
0
152
It has been said that HIV cannot be cured since the virus propagates in places beyond the reach of antiviral agents. New research from Karolinska Institutet suggests, however, that this view is incorrect.
Nov 17, 2016
0
14
